Small ubiquitin-like modifier (SUMO) modification is emerging as an important control in transcription regulation. Here, we show that CREB-binding protein (CBP), a versatile transcriptional coactivator for numerous transcription factors in response to diverse signaling events, can be modified by SUMO-1 at lysine residues 999, 1034 and 1057 both in vitro and in vivo. Mutation of the SUMO acceptor residue lysine residues either individually or in combination enhanced CBP transcriptional activity, and expression of a SUMO protease SENP2 potentiated the transcriptional activity of CBP wild-type but not its sumoylation mutant, indicating that SUMO modification negatively regulates CBP transcriptional activity. Furthermore, we demonstrated an interaction of SUMO-1-modified CBP with the transcriptional corepressor Daxx, and an essential role of Daxx in mediating SUMO-dependent transcriptional regulation of CBP through HDAC2 recruitment. Together, our findings indicate that SUMO modification and subsequent recruitment of Daxx represent a novel mechanism in modulating CBP transcriptional potential.
Introduction
Sumoylation, the covalent attachment of the SUMO peptide to lysine residues of targeted substrate, has recently emerged as an important mechanism in transcriptional control (1) (2) (3) . With an increasing number of sumoylated transcription factors and cofactors being identified, SUMO modification, in most cases, appears to repress the activity of targeted transcriptional activators through altering their sub-compartmentalization and/or molecular interaction properties. We have recently demonstrated that a transcriptional corepressor Daxx can bind to sumoylated androgen receptor and sumoylated Smad4 transcription factor and confer the SUMO-dependent transcriptional repression (4, 5) . Furthermore, we also showed that Daxx-mediated transrepression on glucocorticoid receptor activity can be relieved by 
Sumoylation of CBP
We first performed sumoylation assays both in vitro and in vivo. As shown in Figure 1A To map the sumoylation site(s) within CBP, ten fragments encompassing the entire mouse CBP ( Figure 1D , top panel) were subjected to in vivo sumoylation assays. It is noteworthy that CBP fragment #5 (CBP5) containing amino acid residues 
SUMO-1 Modification of CBP Occurs at

Lys999, 1034, and 1057
We further defined the CBP sumoylation 
Sumoylation Suppresses the Transcriptional Activity of CBP
We next examined whether sumoylation regulates the transactivation activity of CBP. Because CBP does not bind to DNA on its own, the intrinsic transactivation activity of CBP was assessed by
Gal-CBP fusion protein in which CBP was linked to 
